Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

While I see generative AI emerging as healthcare’s most transformative disruptor, its full potential relies on robust data ...

Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive Analysis for Clinical Trial Success BOSTON, March 24, 2025 /PRNewswire/ -- PhaseV ...

The landscape of clinical trials has undergone significant changes, as highlighted in the current Series of six papers published in The Lancet Global Health. The WHO guidance provides a comprehensive ...

The primary value of placebo controls in clinical trials is the minimization of bias.

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...

Researchers at University of Tsukuba investigated the changes in the primary evaluation items in phase II clinical trials for glioblastoma, a type of brain tumor. Recently, the items have become more ...

The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

The All India Institute of Medical Sciences (AIIMS), Delhi is expected to run human trials on India's first indigenously ...